Heartsciences Inc (HSCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 576 | 1,661 | 1,931 | 3,076 | 4,273 |
| Inventories | 676 | 676 | 677 | 678 | 678 |
| Other current assets | 324 | 216 | 40 | 40 | 40 |
| TOTAL | $2,029 | $2,697 | $2,870 | $4,127 | $5,437 |
| Non-Current Assets | |||||
| PPE Net | 59 | 61 | 61 | 64 | 71 |
| Other Non-Current Assets | 510 | 529 | 549 | 580 | 60 |
| TOTAL | $569 | $591 | $610 | $644 | $131 |
| Total Assets | $2,598 | $3,287 | $3,480 | $4,771 | $5,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 455 | 631 | 1,041 | 795 | 456 |
| Accrued Expenses | 631 | 386 | 645 | 891 | 506 |
| Other current liabilities | 241 | 49 | 170 | 292 | 389 |
| TOTAL | $1,898 | $1,833 | $1,985 | $3,139 | $1,542 |
| Non-Current Liabilities | |||||
| Long Term Debt | 500 | 500 | 1,000 | 0 | 1,000 |
| Other Non-Current Liabilities | 720 | 724 | 753 | 549 | 138 |
| TOTAL | $1,220 | $1,224 | $1,753 | $549 | $1,138 |
| Total Liabilities | $3,118 | $3,057 | $3,738 | $3,688 | $2,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109 | 104 | 97 | 82 | 82 |
| Common Shares | 11 | 0 | 8 | 8 | 8 |
| Retained earnings | -62,124 | -60,757 | -59,125 | -57,783 | -55,976 |
| TOTAL | $-520 | $231 | $-258 | $1,083 | $2,887 |
| Total Liabilities And Equity | $2,598 | $3,287 | $3,480 | $4,771 | $5,567 |